Forskning
Udskriv Udskriv
Switch language
Rigshospitalet - en del af Københavns Universitetshospital
Udgivet

Plasma levels of apolipoprotein E, APOE genotype, and all-cause and cause-specific mortality in 105 949 individuals from a white general population cohort

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

DOI

  1. Prevalence of infective endocarditis in patients with positive blood cultures: a Danish nationwide study

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Percutaneous coronary intervention in cancer patients: a report of the prevalence and outcomes in the United States

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Patients with longer life expectancy: what measures are needed?

    Publikation: Bidrag til tidsskriftLederForskning

  1. Early life exposures to perfluoroalkyl substances in relation to adipokine hormone levels at birth and during childhood

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Impact of LDL cholesterol on microvascular versus macrovascular disease: A Mendelian Randomization Study

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Residual vascular risk in diabetes - Will the SPPARM alpha concept hold the key?

    Publikation: Bidrag til tidsskriftReviewForskningpeer review

  4. Low LDL cholesterol by PCSK9 variation reduces cardiovascular mortality

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Vis graf over relationer

AIMS: To determine whether plasma apoE levels and APOE genotype are associated with all-cause and cause-specific mortality.

METHODS AND RESULTS: Using a prospective cohort design with 105 949 white individuals from the general population, we tested the association between plasma apoE at study enrolment and death during follow-up, and whether this was independent of APOE genotype. We confirmed the well-known association between APOE genotypes and mortality. For all-cause, cardiovascular, and cancer mortality, high levels of apoE were associated with increased risk, while for dementia-associated mortality low levels were associated with increased risk. For the highest vs. the fifth septile of plasma apoE, hazard ratios (HRs) were 1.20 (95% confidence interval 1.12-1.28) for all-cause mortality, 1.28 (1.13-1.44) for cardiovascular mortality, and 1.18 (1.05-1.32) for cancer mortality. Conversely, for the lowest vs. the fifth septile the HR was 1.44 (1.01-2.05) for dementia-associated mortality. Results were similar in analyses restricted to APOE ɛ33 carriers. Examining genetically determined plasma apoE, a 1 mg/dL increase conferred risk ratios of 0.97 (0.92-1.03) for cardiovascular mortality and 1.01 (0.95-1.06) for cancer mortality, while a 1 mg/dL decrease conferred a risk ratio of 1.70 (1.36-2.12) for dementia-associated mortality.

CONCLUSION: High plasma levels of apoE were associated with increased all-cause, cardiovascular, and cancer mortality, however of a non-causal nature, while low levels were causally associated with increased dementia-associated mortality.

OriginalsprogEngelsk
TidsskriftEuropean Heart Journal
Vol/bind40
Udgave nummer33
Sider (fra-til)2813-2824
Antal sider12
ISSN0195-668X
DOI
StatusUdgivet - 1 sep. 2019

Bibliografisk note

© The Author(s) 2019. Published by Oxford University Press on behalf of the European Society of Cardiology.

ID: 58188910